PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of acssdACS PublicationsThis JournalSearchSubmit a manuscript
Chemical Research in Toxicology
 
Chem Res Toxicol. 2011 November 21; 24(11): 1833–1835.
Published online 2011 October 26. doi:  10.1021/tx200435d
PMCID: PMC3221470

Tobacco-Specific Nitrosamine-Derived O2-Alkylthymidines Are Potent Mutagenic Lesions in SOS-Induced Escherichia coli

Abstract

An external file that holds a picture, illustration, etc.
Object name is tx-2011-00435d_0004.jpg

To investigate the biological effects of the O2-alkylthymidines induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), we have replicated a plasmid containing O2-methylthymidine (O2-Me-dT) or O2-[4-(3-pyridyl-4-oxobut-1-yl]thymidine (O2-POB-dT) in Escherichia coli with specific DNA polymerase knockouts. High genotoxicity of the adducts was manifested in the low yield of transformants from the constructs, which was 2–5% in most strains but increased 2–4-fold with SOS. In the SOS-induced wild type E. coli, O2-Me-dT and O2-POB-dT induced 21% and 56% mutations, respectively. For O2-POB-dT, the major type of mutation was T → G followed by T → A, whereas for O2-Me-dT, T → G and T → A occurred in equal frequency. For both lesions, T → C also was detected in low frequency. The T → G mutation was reduced in strains with deficiency in any of the three SOS polymerases. By contrast, T → A was abolished in the pol V strain, while its frequency in other strains remained unaltered. This suggests that pol V was responsible for the T → A mutations. The potent mutagenicity of these lesions may be related to NNK mutagenesis and carcinogenesis.

The tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N′-nitrosonornicotine (NNN) are potent carcinogens in laboratory animals, inducing tumors at sites comparable to those found in smokers.1,2 NNK is a potent lung carcinogen, but it also induces tumors in the liver, nasal cavity, and pancreas.3,4 NNN induces tumors in the esophagus, nasal cavity, and respiratory tract.1,5 Metabolic activation of both NNK and NNN by cytochrome P450 is required for their DNA binding, mutagenicity, and carcinogenicity.(1) NNK is metabolized to generate either a methylating agent or a pyridyloxobutylating agent, whereas NNN is metabolized only to the latter. The methylation pathway gives rise to multiple methyl (Me) adducts. 7-Me-dG and O6-Me-dG, have been identified in NNK-treated rodents,2,6,7 but other methylation products,(8) including O2-Me-dC and O2-Me-dT, are also formed. O2-Me-pyrimidines are repaired in vitro by E. coli AlkA,9,10 but otherwise, their biological properties are largely unknown. The pyridyloxobutylation pathway leads to four 4-(3-pyridyl)-4-oxobutyl (POB) adducts in vivo: O6-POB-dG, 7-POB-dG, O2-POB-dC, and O2-POB-dT.2,1113

It is noteworthy that O6-POB-dG has been shown to be mutagenic in E. coli and mammalian cells,(14) but it is present in very low levels in NNK-treated A/J mice and rats,15,16 In contrast, O2-POB-dT is the most persistent POB adduct in the lung and liver of male F344 rats.(16) When the mutagenicity of a model pyridyloxobutylating agent, 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone (NNKOAc), was investigated in CHO cells, it induced point mutations primarily at AT base pairs, suggesting that O2-POB-dT might be mutagenic.(17)

In order to determine the replication properties of the two O2-alkyl-dT adducts formed by the methylation and pyridyloxobutylation pathway, we have constructed single-stranded pMS2 plasmids containing a single O2-Me-dT or O2-POB-dT (Chart 1 shows the structures), which were replicated in several isogenic strains of E. coli with specific DNA polymerase knockouts. The lesion repair capability of the strains remains unaltered, but single-stranded plasmids are inefficient substrates for DNA repair prior to the first round of replication. Viability was determined by a comparison of the colony-forming units obtained per microgram of the adducted construct relative to the control, which also reflected the lesion bypass efficiency. As shown in Figure Figure1,1, the yield of transformants from each adducted construct dropped significantly, with the bulkier O2-POB-dT being the more toxic. Upon induction of SOS, the yield of transformants increased about 2–4-fold in most E. coli strains. For example, in the wild type strain, transformants from the O2-Me-dT construct were 4.5 ± 0.7 and 15.1 ± 2.6% relative to the control, without and with SOS, respectively, whereas the O2-POB-dT construct generated 2.7 ± 0.2 and 6.7 ± 1.7% progeny, respectively, for the same.

Figure 1
Viability of O2-Me-dT and O2-POB-dT without (open bars) and with (closed bars) SOS in different E. coli strains. The data represent the means and standard deviations of at least three independent experiments.
Chart 1
Structures of O2-Methylthymidine and O2-Pyridyloxobutylthymidine

That the SOS polymerases are responsible for survival was confirmed in the strain that lacks pol II, pol IV, and pol V. The yield of transformants from both lesion-containing constructs was approximately 1% in this strain, either with or without prior UV irradiation of the host (Figure (Figure1).1). We conclude that the O2-alkyl-dT adducts are replication blocking lesions, but increased TLS occurs with the SOS DNA polymerases. DNA alkylation products, including the extensively studied O6-alkyl-dG adducts, have been reported to partially block DNA synthesis.(18) Several other alkylated nucleosides, including 1-Me-dA, 3-Me-dC, 3-ethyl-dC, 1-Me-dG, and 3-Me-dT, are also blocks of DNA replication.(19) However, the blockages of the first three are completely removed in strains expressing AlkB, whereas the last two exhibited the strongest blocks.(19) Although these studies used different methods of analysis, the data in the current work taken together with the earlier studies imply that the O2-Me-dT and O2-POB-dT adducts are two of the strongest replication blocking DNA alkylation products.

To determine the frequency of miscoding, we analyzed the progeny plasmid by oligonucleotide hybridization followed by DNA sequencing. In the wild type strain, without SOS, 96–99% progeny contained a T at the O2-alkyl-dT site, indicating predominantly correct read-through by a DNA polymerase, most likely pol III (Supporting Information, Table S1 and S2). With SOS, mutation frequency (MF) increased to 21% and 56% for O2-Me-dT and O2-POB-dT, respectively, which indicates a high frequency of errors in TLS by the SOS DNA polymerases (Supporting Information, Table S1 and S2). Most mutations were targeted base substitutions, though a low frequency of targeted T deletions and semitargeted mutations also occurred (Supporting Information, Table S1 and S2). Figure Figure22 shows the relative population of each type of base substitution mutants relative to unaltered progeny in various SOS-induced strains, and it is apparent from this figure how each SOS DNA polymerase influences the mutational outcome. In contrast to high level of mutagenesis in the SOS-induced wild type strain, no mutants were isolated from the strain that lacks pol II, pol IV, and pol V. In the wild type strain, for O2-Me-dT, both T → G and T → A occurred at approximately 9% frequency (Figure (Figure22 and Supporting Information, Table S1), but T → G was the dominant mutation at 37% compared to 12% T → A induced by O2-POB-dT (Figure (Figure22 and Supporting Information, Table S2). For both lesions, T → A mutations were completely eliminated in the pol V-deficient strain, even though it remained approximately the same in pol II- and pol IV-deficient strains relative to the wild type (Figure (Figure22 and Supporting Information, Table S1 and S2). The frequency of T → G, however, was reduced in each strain with a deficiency in any of the SOS polymerases, but the reduction was more pronounced in pol IV- and pol V-deficient strains. T → C mutations occurred only in the 3–5% and 5–7% frequency for O2-Me-dT and O2-POB-dT, respectively, but they dropped significantly in pol IV- and pol V-deficient strains. We conclude that for both lesions, T → A is induced by pol V, whereas all three SOS DNA polymerases contribute to T → G mutations. T → C mutations were likely induced by both pol IV and pol V.

Figure 2
Progeny analysis of the replication of O2-Me-dT and O2-POB-dT constructs in different E. coli strains with SOS. The bases A (black), G (blue), C (green), and T (red) at the lesion site show the percentage of each base substitution mutant and correct base, ...

To our knowledge, this is the first investigation of the replication of site-specific O2-alkylthymidines in a cell. However, in vitro replication studies of O2-ethyl-dT have been reported,20,21 which showed that it blocks replication by T7 DNA polymerase and the Klenow fragment of the E. coli DNA polymerase I. These investigations also showed that incorporation of dA opposite O2-ethyl-dT inhibits DNA synthesis, whereas the DNA chain is more efficiently extended when dT is incorporated opposite the lesion. The current work in E. coli demonstrates that in the absence of TLS polymerases, bypass of O2-alkyl-dT is inefficient but accurate, whereas increased bypass by the TLS polymerases accompanies error-prone replication. Our study also suggests that pol V is the most error-prone of the three SOS polymerases and that only pol V incorporates dT opposite O2-alkyl-dT. Regardless of the types of mutations, our observation that O2-POB-dT is strongly mutagenic in E. coli underscores the risk posed by NNK and NNN since it is the most persistent adduct in experimental animals. Future studies of the repair kinetics of the O2-alkyl-dT in comparison to O6-alkyl-dG adducts in various organs may provide deeper insight into the roles of these mutagenic adducts in the carcinogenicity of NNK and NNN.

Acknowledgments

We are grateful to G. Walker (MIT, Cambridge, MA) for the E. coli strains and M. Moriya (SUNY, Stony Brook, NY) for the pMS2 plasmid. The modified oligodeoxynucleotides were synthesized and characterized in the Macromolecular Synthesis and Proteomics and Mass Spec Cores of the Penn State College of Medicine.

Glossary

Abbreviations

NNK
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
NNN
N′-nitrosonornicotine
Me
methyl
O2-Me-dT
O2-methylthymidine
POB
4-(3-pyridyl)-4-oxobutyl
O2-POB-dT
O2-[4-(3-pyridyl-4-oxobut-1-yl]thymidine
TLS
translesion synthesis
MF
mutation frequency

Funding Statement

National Institutes of Health, United States

Supporting Information Available

Mutation data, materials, and detailed experimental procedures. This material is available free of charge via the Internet at http://pubs.acs.org.

Notes

This work was supported by the National Institute of Environmental Health Sciences Grants ES013324 and ES09127.

Supplementary Material

References

  • Hecht S. S. (1998) Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol. 11, 559–603. [PubMed]
  • Peterson L. A. (2010) Formation, repair, and genotoxic properties of bulky DNA adducts formed from tobacco-specific nitrosamines. J. Nucleic Acids 10.4061/2010/284935. [PMC free article] [PubMed]
  • Rivenson A.; Hoffmann D.; Prokopczyk B.; Amin S.; Hecht S. S. (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res. 48, 6912–6917. [PubMed]
  • Hecht S. S.; Spratt T. E.; Trushin N. (1988) Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine. Carcinogenesis 9, 161–165. [PubMed]
  • McIntee E. J.; Hecht S. S. (2000) Metabolism of N′-nitrosonornicotine enantiomers by cultured rat esophagus and in vivo in rats. Chem. Res. Toxicol. 13, 192–199. [PubMed]
  • Hecht S. S.; Trushin N.; Castonguay A.; Rivenson A. (1986) Comparative tumorigenicity and DNA methylation in F344 rats by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-nitrosodimethylamine. Cancer Res. 46, 498–502. [PubMed]
  • Peterson L. A.; Hecht S. S. (1991) O6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung. Cancer Res. 51, 5557–5564. [PubMed]
  • Shrivastav N.; Li D.; Essigmann J. M. (2010) Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation. Carcinogenesis 31, 59–70. [PubMed]
  • McCarthy T. V.; Karran P.; Lindahl T. (1984) Inducible repair of O-alkylated DNA pyrimidines in Escherichia coli. EMBO J. 3, 545–550. [PubMed]
  • Ahmmed Z.; Laval J. (1984) Enzymatic repair of O-alkylated thymidine residues in DNA: involvement of a O4-methylthymine-DNA methyltransferase and a O2-methylthymine DNA glycosylase. Biochem. Biophys. Res. Commun. 120, 1–8. [PubMed]
  • Wang L.; Spratt T. E.; Liu X. K.; Hecht S. S.; Pegg A. E.; Peterson L. A. (1997) Pyridyloxobutyl adduct O6-[4-oxo-4-(3-pyridyl)butyl]guanine is present in 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone-treated DNA and is a substrate for O6-alkylguanine-DNA alkyltransferase. Chem. Res. Toxicol. 10, 562–567. [PubMed]
  • Wang M.; Cheng G.; Sturla S. J.; Shi Y.; McIntee E. J.; Villalta P. W.; Upadhyaya P.; Hecht S. S. (2003) Identification of adducts formed by pyridyloxobutylation of deoxyguanosine and DNA by 4-(acetoxymethylnitrosamino)-1-(3-pyridyl)-1-butanone, a chemically activated form of tobacco specific carcinogens. Chem. Res. Toxicol. 16, 616–626. [PubMed]
  • Hecht S. S.; Villalta P. W.; Sturla S. J.; Cheng G.; Yu N.; Upadhyaya P.; Wang M. (2004) Identification of O2-substituted pyrimidine adducts formed in reactions of 4-(acetoxymethylnitrosamino)- 1-(3-pyridyl)-1-butanone and 4-(acetoxymethylnitros- amino)-1-(3-pyridyl)-1-butanol with DNA. Chem. Res. Toxicol. 17, 588–597. [PubMed]
  • Pauly G. T.; Peterson L. A.; Moschel R. C. (2002) Mutagenesis by O(6)-[4-oxo-4-(3-pyridyl)butyl]guanine in Escherichia coli and human cells. Chem. Res. Toxicol. 15, 165–169. [PubMed]
  • Wang M.; Cheng G.; Villalta P. W.; Hecht S. S. (2007) Development of liquid chromatography electrospray ionization tandem mass spectrometry methods for analysis of DNA adducts of formaldehyde and their application to rats treated with N-nitrosodimethylamine or 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Chem. Res. Toxicol. 20, 1141–1148. [PubMed]
  • Lao Y.; Yu N.; Kassie F.; Villalta P. W.; Hecht S. S. (2007) Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem. Res. Toxicol. 20, 235–245. [PubMed]
  • Li L.; Perdigao J.; Pegg A. E.; Lao Y.; Hecht S. S.; Lindgren B. R.; Reardon J. T.; Sancar A.; Wattenberg E. V.; Peterson L. A. (2009) The influence of repair pathways on the cytotoxicity and mutagenicity induced by the pyridyloxobutylation pathway of tobacco-specific nitrosamines. Chem. Res. Toxicol. 22, 1464–1472. [PubMed]
  • Pauly G. T.; Hughes S. H.; Moschel R. C. (1995) Mutagenesis in Escherichia coli by three O6-substituted guanines in double-stranded or gapped plasmids. Biochemistry 34, 8924–8930. [PubMed]
  • Delaney J. C.; Essigmann J. M. (2004) Mutagenesis, genotoxicity, and repair of 1-methyladenine, 3-alkylcytosines, 1-methylguanine, and 3-methylthymine in alkB Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 101, 14051–14056. [PubMed]
  • Bhanot O. S.; Grevatt P. C.; Donahue J. M.; Gabrielides C. N.; Solomon J. J. (1992) In vitro DNA replication implicates O2-ethyldeoxythymidine in transversion mutagenesis by ethylating agents. Nucleic Acids Res. 20, 587–594. [PubMed]
  • Grevatt P. C.; Solomon J. J.; Bhanot O. S. (1992) In vitro mispairing specificity of O2-ethylthymidine. Biochemistry 31, 4181–4188. [PubMed]

Articles from ACS AuthorChoice are provided here courtesy of American Chemical Society